Maintenance Notice (4:00 AM November 1 - 9:30 AM November 1, 2025): This website is scheduled to be unavailable due to maintenance. We appreciate your patience and understanding.
Published TCIMAIL newest issue No.199
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 128607-22-7 | Product Number: O0441
Ospemifene
×
![]()
×
Purity: >98.0%(GC)
Synonyms:
Product Documents:
| Size | Unit Price | Belgium | Japan* | Quantity |
|---|---|---|---|---|
| 100MG |
€98.00
|
1 | 15 |
|
| 1G |
€639.00
|
2 | 27 |
|
*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).
| Product Number | O0441 |
Purity / Analysis Method 
|
>98.0%(GC) |
| Molecular Formula / Molecular Weight | C__2__4H__2__3ClO__2 = 378.90 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature
|
Refrigerated (0-10°C) |
| Condition to Avoid | Heat Sensitive |
| Packaging and Container
|
100MG-Glass Bottle with Plastic Insert (View image) |
| CAS RN | 128607-22-7 |
| Reaxys Registry Number | 10283864 |
| PubChem Substance ID | 253662436 |
| MDL Number | MFCD00871890 |
Specifications
| Appearance | White to Almost white powder to crystal |
| Purity(GC) | min. 98.0 % |
Properties (reference)
GHS
| Pictogram |
|
| Signal Word | Warning |
| Hazard Statements | H361 : Suspected of damaging fertility or the unborn child. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P202 : Do not handle until all safety precautions have been read and understood. P201 : Obtain special instructions before use. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection/ hearing protection. P308 + P313 : IF exposed or concerned: Get medical advice/ attention. P405 : Store locked up. |
Related Laws:
Transport Information:
| HS Number | 2909498090 |
Application
選択的エストロゲン受容体調節剤 (SERM)，オスペミフェン
Ospemifene (FC1271a) was first reported as a metabolite of toremifene [T2832] which is an antiestrogen and a hormonal antitumor agent. Ospemifene is the first non-hormonal estrogen receptor agonist/antagonist or selective estrogen receptor modulator (SERM). It specifically binds to the estrogen receptor α and β with affinity closely similar to that of toremifene and tamoxifen [T2510]. Ospemifene is currently used for treatment of vulvovaginal atrophy (VVA). In addition, the antiestrogenic activity of ospemifene in several breast cancer animal models has been reported. (The product is for research purpose only.)
References
- Metabolism of toremifene in the rat
- Selective estrogenic effects of a novel triphenylethylene compound, FC1271a, on bone, cholesterol level, and reproductive tissues in intact and ovariectomized rats
- Pharmacokinetics of selective estrogen receptor modulators (a review)
- Selective estrogen receptor modulators for postmenopausal osteoporosis: current state of development (a review)
- Tissue selectivity of ospemifene: Pharmacologic profile and clinical implications (a review)
- Ospemifene, vulvovaginal atrophy, and breast cancer (a review)
PubMed Literature
Documents
Product Articles
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.